Mon, March 27, 2023

Judah Frommer Reiterated (ATAI) at Buy and Held Target at $9 on, Mar 27th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-9-on-mar-27th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Judah Frommer of Credit Suisse, Reiterated "Atai Life Sciences N.V." (ATAI) at Buy and Held Target at $9 on, Mar 27th, 2023.

Judah has made no other calls on ATAI in the last 4 months.



There are 2 other peers that have a rating on ATAI. Out of the 2 peers that are also analyzing ATAI, 0 agree with Judah's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Judah


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Thursday, January 19th, 2023
  • Neena Bitritto-Garg of "Citigroup" Maintained at Strong Buy with Decreased Target to $10 on, Monday, January 9th, 2023